Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 628Neoplasm Metastasis 38HER2-positive Breast Cancer 33Breast Neoplasms, Male 30Inflammatory Breast Neoplasms 20Brain Neoplasms 18Stomach Neoplasms 16Neoplasms 16Carcinoma, Non-Small-Cell Lung 14Triple Negative Breast Neoplasms 12Colorectal Neoplasms 10Pancreatic Neoplasms 9Endometrial Neoplasms 9Ovarian Neoplasms 8Cardiotoxicity 8Lung Neoplasms 7Esophageal Neoplasms 7Breast Diseases 7Uterine Cervical Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Prostatic Neoplasms 5Pathologic Complete Response 5Carcinoma, Ductal, Breast 5Urinary Bladder Neoplasms 4Sarcoma 4HER2-positive Early Breast Cancer 4HER2 Positive Breast Cancer 4Carcinoma, Renal Cell 4Carcinoma, Hepatocellular 4Thyroid Neoplasms 3

Interventions

eribulin 1Trastuzumab 1Paclitaxel 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Ginkgo Extract 1Fluorodeoxyglucose F18 1Exercise Therapy 1Doxorubicin 1Docetaxel 1Cycloserine 1Cyclophosphamide 1Carnitine 1Carboplatin 1Aromatase Inhibitors 1Amifostine 1Acupuncture Therapy 12,2'-dithiodiethanesulfonic acid 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurotoxicity Syndromes × Trastuzumab × Breast × Clear all
NCT00755313 2017-11-24

Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer

University of California, San Francisco

Completed
81 enrolled
Breast

Breast Neoplasms, Fatigue, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡